UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  October 28, 2004

 

NEUROMETRIX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-50856

 

04-3308180

(State or other jurisdiction of
incorporation or organization)

 

Commission file number

 

(I.R.S. Employer
Identification No.)

 

62 Fourth Avenue

Waltham, Massachusetts     02451

(Address of principal executive offices) (Zip code)

 

Registrant’s telephone number, including area code: (781) 890-9989

 

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 2.02.  Results of Operations and Financial Condition.

 

On October 28, 2004, NeuroMetrix, Inc. issued a press release announcing its financial results for the third quarter of 2004.  The full text of the press release and the related attachments are furnished as Exhibit 99.1 hereto.

 

Item 9.01.  Financial Statements and Exhibits.

 

(c)  Exhibits.

 

99.1                                       Press Release of NeuroMetrix, Inc. dated October 28, 2004, including attachments.

 

 

[Remainder of page left blank intentionally]

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be filed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NEUROMETRIX,INC.

 

 

 

Dated: October 28, 2004

 

By:

/s/ Shai N. Gozani, M.D., Ph.D.

 

 

Shai N. Goznai, M.D., Ph.D.

 

 

President and Chief Executive Officer

 

 

 

 

3


 

Exhibit Index

 

99.1                           Press Release of NeuroMetrix, Inc. dated October 28, 2004, including attachments.

 

4